Michael Reardon, MD

Biography

Dr. Michael J. Reardon is a native Houstonian who attended Baylor College of Medicine where he graduated with honors and as a member of AOA. He did his general surgery residency under Dr. Michael DeBakey and cardiothoracic residency under Dr. Denton Cooley. He joined the staff of the Houston Methodist Hospital in 1985 and ran a private practice until 1993. He then joined the full time faculty of BCM rising to Professor of Surgery with tenure, Chief of Cardiothoracic Surgery and Director of the thoracic residency program. He subsequently joined the academic group at the HMH as Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery.

His interests have centered on aortic surgery, cardiac valve surgery and cardiac tumors. His recent research and clinical interests have focused on minimally invasive, catheter-based approaches to these areas. He serves on the national steering committee for the CoreValve, SurTAVI and reprise III TAVR trials and as national surgical PI on the SurTAVI trial, reprise III trial and the Gore type A dissection trial. Dr. Reardon also serves as the international surgical PI for the Reprise III trial.

He holds the position of Clinical Professor of Cardiothoracic Surgery at MD Anderson Cancer Center and created the multi-institution, multidisciplinary cardiac tumor team with HMH and MDA. He has operated on more primary cardiac sarcomas than any other surgeon globally and written extensively on this topic. Dr. Reardon's group recently published the largest series of surgically treated primary cardiac sarcomas in the world. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience PMID 26476808

He has served as elected president of the medical staff for the HMH and received numerous awards including the Overstreet Award and Noon Award. He currently holds the Allison Family Distinguished Chair of Cardiovascular Research and is divides his time between building innovative clinical, research and educational programs.

 

Description of Research

He has been the principal and co-investigator on several industry and government-sponsored clinical trials and research initiatives, and he is currently on the national steering and screening committees for the Medtronic CoreValve US Pivotal Trial and the international steering committee for the SurTAVI Trial, for which he is also a national surgical principal investigator. His research interests include cardiac tumor treatment, catheter based approaches to structural heart disease, catheter based and open aortic disease treatment Having published more than 300 articles and abstracts, Dr. Reardon conducts peer reviews for publications such as the Annals of Thoracic Surgery and Circulation and is the associate editor of surgery for the Methodist DeBakey Cardiovascular Journal.

 

Areas Of Expertise

Cardiac tumor treatment Catheter based approaches to structural heart disease Catheter based and open aortic disease treatments Cardiac valve disease Aortic surgery Cardiac tumor surgery Complex cardiac surgery.

 

Education & Training

MD, Baylor College of Medicine

Residency, Baylor College of Medicine

Certificate, Healthcare Management, Rice University

Fellow, Harvard University Alley-Sheridan School of Government

Residency, Texas Heart Institute

 

Active Clinical Trials
PERIGON Pivotal Trial

NCT02088554

CoreValve High Risk Surgical Patients

NCT01240902

 

Publications

Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve. Bleiziffer, S, Erlebach, M, Simonato, M, Pibarot, P, Webb, J, Capek, L, Windecker, S, George, I, Sinning, J-M, Horlick, E, Napodano, M, Holzhey, DM, Petursson, P, Cerillo, A, Bonaros, N, Ferrari, E, Cohen, MG, Baquero, G, Jones, TL, Kalra, A, Reardon, MJ, Chhatriwalla, A, Gama Ribeiro, V, Alnasser, S, Van Mieghem, NM, Rustenbach, CJ, Schofer, J, Garcia, S, Zeus, T, Champagnac, D, Bekeredjian, R, Kornowski, R, Lange, R & Dvir, D 2018, Heart (British Cardiac Society), vol 104, no. 10, pp. 828-834. DOI: 10.1136/heartjnl-2017-312422

 

Very Late Migration of Balloon-Expandable Transcatheter Aortic Valve. Kalra, A, Avenatti, E, Chinnadurai, P, Reardon, MJ, Kleiman, NS, Little, SH & Barker, CM 2018, Journal of Invasive Cardiology, vol 30, no. 4, pp. E28-E30.

 

The devil is in the details. Reardon, MJ 2018, Journal of Thoracic and Cardiovascular Surgery. DOI: 10.1016/j.jtcvs.2018.03.025

 

Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk: An Analysis From the REPRISE III Randomized Controlled Trial (Repositionable Percutaneous Replacement of Stenotic Aortic Valve through Implantation of Lotus Valve System - Randomized Clinical Evaluation)

Asch, FM, Vannan, MA, Singh, S, Khandheria, B, Little, SH, Allocco, DJ, Meredith, IT, Feldman, TE, Reardon, MJ & Weissman, NJ 2018, Circulation. DOI: 10.1161/CIRCULATIONAHA.118.034129, 10.1161/CIRCULATIONAHA.118.034

 

When to SAVR in the age of TAVR? A perspective on surgical aortic valve replacement in 2018

Wyler von Ballmoos, MC, Barker, CM, Reul, RM, Dadu, R, Ramchandani, M, Kleiman, NS & Reardon, MJ 2018, Cardiovascular Revascularization Medicine, vol 19, no. 2, pp. 139-141. DOI: 10.1016/j.carrev.2018.03.014